Atamyo Therapeutics
Last verified 2026-05-02. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $2.7Mattributed |
|---|---|
| Latest round | grant, $2.7M, 2024-09-01attributed |
| Founded | 2020 |
| Headquarters | Evry, France |
| Industry | biotech |
| Stage | unknown |
| Website | atamyo.com |
Atamyo brings to patients with musculoskeletal diseases a new generation of high-performing gene therapies with enhanced safety and efficacy. This name conveys the spirit of the company in its commitment to improve the life of patients affected by neuromuscular diseases with life-long efficient. Our Pipeline At Atamyo, we use our expertise in ge.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-09-01 | grant | $2.7M | undisclosed |
Detected tech stack
WordPress 6.7.5, Apache HTTP Server 2.4.38, Lightbox, scrollreveal 6.7.5, Slick, Debian, Contact Form 7 5.6.3, WP Fastest Cache, PHP, MySQL, apache 2.4.38, jquery 3.3.1
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Total raised $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Company existence | self-reported | atamyo.com, read 2026-05-02 |
| Description | self-reported | atamyo.com, read 2026-05-02 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.